PlainRecalls
FDA Drug Moderate Class II Ongoing

Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10

Reported: July 26, 2023 Initiated: June 21, 2023 #D-0923-2023

Product Description

Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10

Reason for Recall

Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

Details

Units Affected
17,548 1000-countbottles
Distribution
Nationwide in the USA
Location
Ranasthalam Mandal, Srikakulam, N/A

Frequently Asked Questions

What product was recalled?
Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10. Recalled by Dr Reddy's Laboratories Limited. Units affected: 17,548 1000-countbottles.
Why was this product recalled?
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 26, 2023. Severity: Moderate. Recall number: D-0923-2023.